FNY Investment Advisers’s Pfizer PFE Stock Holding History

FNY Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-457	Closed	-$11K	–	1345
2025 Q3	$11K	Buy	+457	New	+$11.3K	﹤0.01%	790
2024 Q2	–	Sell	-50	Closed	-$1	–	733
2024 Q1	$1	Buy	+50	New	+$1.39K	﹤0.01%	637
2023 Q4	–	Sell	-40	Closed	-$1K	–	720
2023 Q3	$1K	Buy	+40	New	+$1.42K	﹤0.01%	578
2022 Q4	–	Sell	-40	Closed	-$1K	–	699
2022 Q3	$1K	Sell	40 -225	-85%	-$10.9K	﹤0.01%	602
2022 Q2	$13K	Sell	265 -485	-65%	-$24.7K	0.01%	379
2022 Q1	$38K	Buy	+750	New	+$38.9K	0.04%	290

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FNY Investment Advisers's PFE Position: Q2 2026 in Review

FNY Investment Advisers increased its Pfizer (PFE) stake by 210% in Q2 2026, buying an estimated $888K and bringing the position to 50,150 shares worth $1.21M. The position accounts for 0.43% of the portfolio, ranked #57.

FNY Investment Advisers first reported a position in PFE in Q4 2019 and has held it in 16 quarters since. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

FNY Investment Advisers held 50,150 shares of Pfizer worth $1.21M as of Q2 2026.
FNY Investment Advisers bought 33,960 Pfizer shares in Q2 2026, an estimated $888K.
Pfizer made up 0.43% of FNY Investment Advisers's portfolio in Q2 2026, its #57 holding.
FNY Investment Advisers first reported a position in Pfizer in Q4 2019 and has held it in 16 quarters since.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.